American BioMed Inc. in discussions with potential strategic alliance partners.THE WOODLANDS, Texas--(BUSINESS WIRE)--May 9, 1996--American BioMed Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ABMI ABMI Autologous Bone Marrow Infusion ), of The Woodlands Thursday announced it is currently corresponding with numerous U.S. and International medical companies for the purpose of negotiating a strategic alliance or partnership for its products and technology in respect to domestic and international markets. These products include but are not limited to the OmniCath(r) atherectomy catheter, silicone Foley catheters, as well as the company's eight other patented and FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. approved all silicone balloon catheters and the company's stent technology. The company's President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Steven B. Rash stated, "initiation of these discussions are a direct result of the company taking another positive action to further its strategic business plan and although the company is optimistic about the future outcome of these discussions, there can be no assurance that a contract or strategic alliance with any of these companies will be consummated." American BioMed Inc. is engaged in the development, manufacture and marketing of next generation minimally invasive medical, surgical and diagnostic devices which deliver unique advantages through advanced technology. OmniStent(tm), which incorporates the company's (U.S. and European) patented "endless loop See infinite loop. endless loop - infinite loop " process, offers the physician a choice in configurations and more options (including bifurcations) than any other stent in this $1-billion market. OmniCath(r) is a directional atherectomy catheter that employs deflecting nontraumatizing wires to anchor the cutting window at the atherectomy site. Directional atherectomy is used as an alternative and adjunct to angioplasty and stent procedures intended to treat peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. . Other devices such as unique silicone catheters as well as spinal dissectors are also marketed by the company. CONTACT: Thomas E. Waite & Associates Inc. 407/324-1606, fax 407/324-0664 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion